Beta radiotherapy emitting surgical device and methods of use thereof

• US 8,100,818 B2
• Filed: 07/19/2007
• Issued: 01/24/2012
• Est. Priority Date: 02/22/2001
• Status: Expired due to Fees

• Current Assignee: TDH Partners Incorporated
• Original Assignee: TDH Partners Incorporated
• Inventors: DeJuan, Eugene Jr., Hallen, Paul
• Primary Examiner(s): Marmor, II, Charles A
• Assistant Examiner(s): Burk, Catherine E
• Application Number:
  US11/780,159
• Publication Number:
  US 20070265485A1
• Time in Patent Office: 1,650 Days
• Field of Search: 600 1- 8, 604/4, 604/5, 604/294, 604/521, 606/107, 606/162
• US Class Current: 600/3
• CPC Class Codes: A61N 2005/1089 Electrons
• CPC Class Codes: A61N 5/1017 Treatment of the eye, e.g. for "macular degeneration"

Abstract

A surgical device for localized delivery of beta radiation in surgical procedures, particularly ophthalmic procedures. Preferred surgical devices include a cannula with a beta radiotherapy emitting material at the distal end of the cannula. The surgical device is particularly suitable for use in the treatment of treat Age Related Macular Degeneration (AMD).

Claims

1. A method of treating human eye tissue, comprising:

inserting a radiotherapy ionizing radiation source material into the vitreous chamber of the eye;

positioning the radiation source material within the vitreous and about 3 mm or less from eye tissue to be treated; and

exposing the eye tissue to ionizing radiation emitted from the radiation source material for a time less than 15 minutes.

2. The method of claim 1 including directly contacting the tissue to be treated.

3. The method of claim 1 in which the positioning includes positioning the radiotherapy ionizing radiation source material about 1 mm or less from the tissue to be treated.

4. The method of claim 1 in which the exposing comprises exposing the eye tissue to beta radiation.

5. The method of claim 1 in which the exposing comprises exposing the eye tissue to pure beta radiation.

6. The method of claim 1 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate between about 50 cGy/sec and about 100 cGy/sec.

7. The method of claim 1 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate of at least about 50 cGy/sec.

8. The method of claim 1 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate that is at most about 100 cGy/sec.

9. The method of claim 1 in which the ionizing radiation is unshielded during the exposure to eye tissue.

10. The method of claim 1 in which the inserting comprises inserting the radiotherapy ionizing radiation source material into the vitreous chamber through a vitrectomy port incision.

11. A method of treating human eye tissue, comprising:

inserting the distal end portion of a cannula into the vitreous chamber of a human eye; and

exposing selected eye tissue to ionizing radiation emitted from a radiotherapy ionizing radiation source material located at the distal end portion of the cannula.

12. The method of claim 11 further including positioning the radiotherapy ionizing radiation source material about 3 mm or less from the selected eye tissue.

13. The method of claim 12 including directly contacting the selected eye tissue.

14. The method of claim 11 further including positioning the radiotherapy ionizing radiation source material at distance of at least about 1 mm from the selected eye tissue.

15. The method of claim 11 further including positioning the radiotherapy ionizing radiation source material between about 1 mm and about 3 mm from the selected eye tissue.

16. The method of claim 11 in which the exposing comprises exposing the selected eye tissue to beta radiation.

17. The method of claim 11 in which the exposing comprises exposing the selected eye tissue to pure beta radiation.

18. The method of claim 11 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate between about 50 cGy/sec and about 100 cGy/sec.

19. The method of claim 11 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate of at least about 50 cGy/sec.

20. The method of claim 11 in which the radiotherapy ionizing radiation source material has sufficient energy to provide a dose rate that is at most about 100 cGy/sec.

21. The method of claim 11 in which the selected eye tissue is exposed to said ionizing radiation for a time less than 15 minutes.

22. The method of claim 11 in which the ionizing radiation is unshielded during the exposure to selected eye tissue.

23. The method of claim 11 in which inserting comprises inserting the distal end portion of the cannula into the vitreous chamber through a vitrectomy port incision.